ATE303810T1 - In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe - Google Patents

In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe

Info

Publication number
ATE303810T1
ATE303810T1 AT00915730T AT00915730T ATE303810T1 AT E303810 T1 ATE303810 T1 AT E303810T1 AT 00915730 T AT00915730 T AT 00915730T AT 00915730 T AT00915730 T AT 00915730T AT E303810 T1 ATE303810 T1 AT E303810T1
Authority
AT
Austria
Prior art keywords
dyes
vivo
methods
dysplastic tissue
identifying
Prior art date
Application number
AT00915730T
Other languages
English (en)
Inventor
Douglas D Burkett
Original Assignee
Zila Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zila Inc filed Critical Zila Inc
Application granted granted Critical
Publication of ATE303810T1 publication Critical patent/ATE303810T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/36—[b, e]-condensed, at least one with a further condensed benzene ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Sanitary Thin Papers (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Indole Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00915730T 2000-01-31 2000-01-31 In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe ATE303810T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/002602 WO2001054696A1 (en) 2000-01-31 2000-01-31 In vivo stain compounds and methods of use to identify dysplastic tissue

Publications (1)

Publication Number Publication Date
ATE303810T1 true ATE303810T1 (de) 2005-09-15

Family

ID=21741026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915730T ATE303810T1 (de) 2000-01-31 2000-01-31 In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe

Country Status (23)

Country Link
US (1) US6830743B1 (de)
EP (1) EP1165087B1 (de)
JP (1) JP2003520816A (de)
KR (1) KR100641972B1 (de)
CN (1) CN1219515C (de)
AT (1) ATE303810T1 (de)
AU (1) AU784639B2 (de)
BR (1) BR0009427A (de)
CA (1) CA2366759A1 (de)
CZ (1) CZ20013504A3 (de)
DE (1) DE60022487T2 (de)
DK (1) DK1165087T3 (de)
EA (1) EA003939B1 (de)
ES (1) ES2248061T3 (de)
HU (1) HUP0201634A3 (de)
IL (1) IL145589A0 (de)
MX (1) MXPA01009797A (de)
NO (1) NO322012B1 (de)
PL (1) PL349999A1 (de)
SK (1) SK13782001A3 (de)
TR (1) TR200102815T1 (de)
TW (1) TWI250157B (de)
WO (1) WO2001054696A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462346B2 (en) * 2001-08-28 2008-12-09 Zila Biotechnology, Inc. Light-stabilized(in vivo) stain composition and method of manufacture
US20050089472A1 (en) * 2003-10-22 2005-04-28 Shovers Aaron H. Monitoring the status of a condition of an animal through visually observable indicia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321251A (en) * 1979-12-19 1982-03-23 The United States Of America As Represented By The Department Of Health And Human Services Detection of malignant lesions of the oral cavity utilizing toluidine blue rinse
JPS63187154A (ja) * 1987-01-29 1988-08-02 Kishida Kagaku Kk 酸素検知剤
CA2097695C (en) * 1991-10-31 2000-08-08 Mark J. Malmros Biological stain composition, method of preparation and method of use for delineation of epithelial cancer
US5942410A (en) * 1997-07-07 1999-08-24 Oncometrics Imaging Corp. Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol
US6417003B1 (en) * 1993-01-14 2002-07-09 Zila, Inc. Method and kit for epithelial cancer screening
KR100342342B1 (ko) * 1996-01-16 2002-08-22 자일러, 인코포레이티드 구강암및전암성질환의체내검출을위한방법및조성물
CA2249227A1 (en) * 1997-01-20 1998-07-23 Kyowa Medex Co., Ltd. Methods and reagents for quantitatively determining ascorbic acid
DE19716586C1 (de) * 1997-04-21 1998-08-06 Continental Ag Verfahren zum Ermitteln der Profiltiefe eines Fahrzeugreifens am fahrenden Fahrzeug
US6194573B1 (en) * 1997-11-13 2001-02-27 Zila, Inc. Process for manufacture of in vivo stain composition
US6649144B1 (en) * 2000-02-28 2003-11-18 Zila, Inc. Method for detecting and killing epithelial cancer cells

Also Published As

Publication number Publication date
PL349999A1 (en) 2002-10-21
JP2003520816A (ja) 2003-07-08
MXPA01009797A (es) 2002-11-04
TWI250157B (en) 2006-03-01
HUP0201634A2 (en) 2002-09-28
CA2366759A1 (en) 2001-08-02
DE60022487T2 (de) 2006-07-13
CZ20013504A3 (cs) 2002-04-17
KR100641972B1 (ko) 2006-11-02
AU784639B2 (en) 2006-05-18
NO20014720L (no) 2001-11-27
EP1165087A4 (de) 2003-04-02
WO2001054696A1 (en) 2001-08-02
NO20014720D0 (no) 2001-09-28
HUP0201634A3 (en) 2009-08-28
CN1219515C (zh) 2005-09-21
SK13782001A3 (sk) 2002-02-05
CN1345241A (zh) 2002-04-17
IL145589A0 (en) 2002-06-30
BR0009427A (pt) 2002-07-16
EP1165087A1 (de) 2002-01-02
DE60022487D1 (de) 2005-10-13
EA200101028A1 (ru) 2002-02-28
NO322012B1 (no) 2006-08-07
AU3695600A (en) 2001-08-07
KR20010108431A (ko) 2001-12-07
ES2248061T3 (es) 2006-03-16
DK1165087T3 (da) 2005-11-21
EA003939B1 (ru) 2003-10-30
TR200102815T1 (tr) 2002-05-21
EP1165087B1 (de) 2005-09-07
US6830743B1 (en) 2004-12-14

Similar Documents

Publication Publication Date Title
ATE457780T1 (de) Ein dikationischer diazofarbstoff enthaltende farbstoffzusammensetzung zum färben von keratinischen fasern
DE59912963D1 (de) Medizinisches instrument zum präparieren von gewebe
DE60105295D1 (de) Chinazolinderivate zur behandlung von tumoren
DE69920178D1 (de) Super-elastische gebogene hohlnadel zur medizinischen verwendung
DE50011194D1 (de) Medizinisches Instrument zum Präparieren von Gewebe
DE60238898D1 (de) Oxidative Zusammensetzung zur Behandlung von Keratinfasern, die spezielle Aminosilikone enthält
DE60211106D1 (de) Zusammensetzung zur Oxidationsfärbung von Keratinfasern
ATE452655T1 (de) Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
ATE301703T1 (de) Verwendung von zusammensetzungen zur textilpflege
DE60207288D1 (de) Gewebespezifische fluoreszierende chelate
DE50105185D1 (de) Verfahren zur Herstellung von Dithiazolyldisulfiden
DE602004003607D1 (de) Fluoreszenzfarbstoffzusammensetzung zum Färben von menschlichen Keratinfasern
DE60128640D1 (de) Verfahren zur Herstellung von optisch aktivem 4-Halo-3-Hydroxybutanoat
DE60022487D1 (de) In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe
DE60031108D1 (de) Verfahren zur Herstellung von Vinylamin-Vinylalkohol-Copolymeren und Verwendung davon
DE50109698D1 (de) N-heteroarylmethyl-m-phenylendiamin-derivate enthaltende färbemittel für keratinfasern sowie neue n-heteroarylmethyl-m-phenylendiamin-derivate
ATE525356T1 (de) 2,5-diaminopyridin oxidationsbasen, deren verwendung zur färbung von keratinischen fasern
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
DK0948967T3 (da) Behandling af virussygdom hos svin
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE60227896D1 (de) Verfahen zur Herstellung von Polyalkylphenoxyaminoalkanen
DE60208365D1 (de) Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln
DE60104789D1 (de) Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden
FR2838337B1 (fr) Composition pour la teinture d'oxydation des fibres keratiniques humaines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165087

Country of ref document: EP

REN Ceased due to non-payment of the annual fee